@Oldpa1love it!yep....'life saving'....sounds bloody awesome...

@Oldpa1

love it!
yep....'life saving'....sounds bloody awesome doesn't it

link
WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access


spoiler alert
Clinical trial investigators in 28 countries shared data with WHO, including pre-publication data. Researchers worldwide compiled and analyzed the data. With the support of these critical partnerships, WHO has been able to issue a rapid and trustworthy recommendation for the use of interleukin-6 receptor blockers in severe and critical COVID-19 patients.“These drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical COVID-19. But IL-6 receptor blockers remain inaccessible and unaffordable for the majority of the world,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.

this is IHLs' bread and butter ......visionary team, risk/reward will be off the charts
nothing like it on the ASX......only a few globally as well

big thanks @Oldpa1 ( not sure if its the link you meant but it reveals the shift to the IHL 675A methodology = $$$$$$)

credit mate - sensational find imo

GLA